You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GW786034

Showing 1 - 25 of 93
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Jacksonville, Rochester (Laboratory Biomarker Analysis, Pazopanib Hydrochloride, Pharmacological Study)

Active, not recruiting
  • Solid Neoplasm
  • Laboratory Biomarker Analysis
  • +2 more
  • Jacksonville, Florida
  • +1 more
Jan 25, 2023

Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

Active, not recruiting
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • pazopanib hydrochloride
  • +4 more
  • Chicago, Illinois
  • +4 more
Jul 26, 2022

Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)

Completed
Has Results
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 24, 2021

Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)

Terminated
  • Advanced Cancers
  • Crizotinib (Xalkori)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2021

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Not yet recruiting
  • Locally Advanced Leiomyosarcoma
  • +8 more
  • (no location specified)
Jul 6, 2022

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Metastatic Solid Tumors Trial in San Francisco (PZP115891, PCI-24781)

Recruiting
  • Metastatic Solid Tumors
  • PZP115891, PCI-24781
  • San Francisco, California
    University of California, San Francisco
Aug 23, 2021

Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in United

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Ascorbic Acid
  • Pazopanib Hydrochloride
  • Peoria, Illinois
  • +4 more
Mar 18, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Carcinoma Trial in United States

Completed
Has Results
  • Pancreatic Alpha Cell Carcinoma
  • +4 more
  • Chicago, Illinois
  • +4 more
Jul 14, 2021

Carcinoma, Non-Small Cell Lung, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Pazopanib)

Terminated
Has Results
  • Carcinoma, Non-Small Cell Lung
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 13, 2020

Tumors, Lymphoma Trial run by the NCI (Pazopanib, Pazopanib (GW786034)(GW786034))

Completed
  • Neoplasms
  • Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 19, 2019

Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in

Completed
Has Results
  • Gastrin-Producing Neuroendocrine Tumor
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Boston, Massachusetts
  • +2 more
Mar 25, 2020

Sarcoma, Soft Tissue, Soft Tissue Sarcoma Trial in United States (Pazopanib)

Completed
Has Results
  • Sarcoma, Soft Tissue
  • Soft Tissue Sarcoma
  • Phoenix, Arizona
  • +6 more
Jul 24, 2020

Solid Tumours Trial in Worldwide (Pazopanib)

Completed
Has Results
  • Solid Tumours
  • Long Beach, California
  • +30 more
Jul 27, 2020

Thyroid Carcinoma Trial in France (Continuous pazopanib (Arm A), Intermittent pazopanib (Arm B))

Completed
  • Thyroid Carcinoma
  • Continuous pazopanib (Arm A)
  • Intermittent pazopanib (Arm B)
  • Angers, France
  • +12 more
Aug 14, 2019

Recurrent Thyroid Gland Carcinoma, Stage III Differentiated Thyroid Gland Carcinoma AJCC v7, Stage III Thyroid Gland Medullary

Completed
Has Results
  • Recurrent Thyroid Gland Carcinoma
  • +12 more
  • Laboratory Biomarker Analysis
  • Pazopanib Hydrochloride
  • Scottsdale, Arizona
  • +21 more
Feb 4, 2020

Stage IIA Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in Seattle

Completed
Has Results
  • Stage IIA Adult Soft Tissue Sarcoma
  • +2 more
  • Doxorubicin Hydrochloride
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 1, 2020

Peritoneal Cancer, Ovarian Cancer, Tumors, Ovarian Trial in Australia, Singapore, United States (GW786034)

Completed
Has Results
  • Peritoneal Cancer
  • +3 more
  • GW786034
  • Atlanta, Georgia
  • +9 more
Sep 13, 2018

Solid Tumor Trial in Columbus, Houston (dabrafenib, pazopanib HCl, Correlative studies)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Columbus, Ohio
  • +1 more
Feb 28, 2019

Recurrent Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Laboratory Biomarker Analysis, Pazopanib

Completed
Has Results
  • Recurrent Melanoma
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Laboratory Biomarker Analysis
  • +2 more
  • Jacksonville, Florida
  • +3 more
Sep 21, 2018

Thyroid Gland Anaplastic Carcinoma Trial in United States (radiation, drug, other)

Completed
Has Results
  • Thyroid Gland Anaplastic Carcinoma
  • Intensity-Modulated Radiation Therapy
  • +3 more
  • Birmingham, Alabama
  • +129 more
Jun 28, 2022

NSCLC Trial in France (PAZOPANIB, Placebo)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Ambilly, France
  • +39 more
Sep 20, 2019

Prostate Cancer Trial in Chicago, Durham (Pazopanib, Docetaxel, Prednisone)

Completed
  • Prostate Cancer
  • Chicago, Illinois
  • +1 more
Jun 5, 2018